NCT06676241

Brief Summary

In this study, it is planned to compare ERCP with ES + delayed LC in children, with one-stage LC + ERCP with ES in adults to confirm that ERCP with ES + delayed LC is more suitable for pediatric patients with cholecystocholedocholithiasis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

November 13, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2025

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2025

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

October 27, 2024

Last Update Submit

March 5, 2025

Conditions

Keywords

СholedocholelysisEndoscopic retrograde cholangiopancreatography (ERCP)

Outcome Measures

Primary Outcomes (1)

  • Recurrence of stones in the common bile duct

    The diagnosis of the stone in the common bile duct.

    30 days after ERCP

Secondary Outcomes (10)

  • Bleeding

    30 days after ERCP

  • Perforation

    30 days after ERCP

  • Bile leak

    30 days after ERCP

  • Acute cholangitis

    60 days after ERCP

  • Bile duct stricture

    1 year after ERCP

  • +5 more secondary outcomes

Study Arms (2)

ERCP, EST and simultaneous LC

Patients aged 10-80 years initially underwent ERCP with ES by an endoscopist with the consent of the patient or legal representative. Patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Laparoscopic cholecystectomy was performed immediately after ERCP with ES under general anesthesia

Procedure: endoscopic retrograde cholangiopancreatography; laparoscopic cholecystectomy

ERCP, EST and LC in a delayed manner

Patients aged 0-17 years initially underwent ERCP with ES by an endoscopist with the consent of the patient or legal representative. Patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Laparoscopic cholecystectomy was performed in a delayed manner, not earlier than 7 days after ERCP

Procedure: endoscopic retrograde cholangiopancreatography;laparoscopic cholecystectomy

Interventions

Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed immediately after ERCP with ES under general anesthesia.

Also known as: Cholangiopancreatography, Laparoscopic
ERCP, EST and simultaneous LC

Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patient underwent the endoscopic procedure using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed on a delayed basis no earlier than 7 days after ERCP

Also known as: Cholangiopancreatography, Laparoscopic
ERCP, EST and LC in a delayed manner

Eligibility Criteria

Age0 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

You may qualify if:

  • Informed consent from the patient, child or legal representative
  • Age 0-80 years
  • Acute cholecystitis
  • Choledocholithiasis
  • Intraoperative ERCP
  • Preoperative ERCP followed by cholecystectomy

You may not qualify if:

  • Unwillingness or inability to consent to the study
  • Pregnancy
  • Age \> 80 years
  • Previous ERCP or percutaneous transhepatic biliary drainage
  • Anastomosis in the upper gastrointestinal tract
  • Benign or malignant stricture
  • Preoperative comorbidities: gastrointestinal bleeding, severe liver disease, acute and chronic cholangitis, other known cholestatic hepatopancreatobiliary disease, septic shock.
  • In combination with Mirizzi syndrome and intrahepatic bile duct stones
  • Congenital anomaly of the biliary tract
  • Malignant neoplasms
  • Acute pancreatitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

Moscow, Moscow Oblast, 142636, Russia

Location

MeSH Terms

Conditions

CholedocholithiasisCholecystolithiasisPancreatitisGallstones

Interventions

Cholangiopancreatography, Endoscopic RetrogradeCholecystectomy, LaparoscopicLaparoscopy

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisGallbladder DiseasesPancreatic DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresCholecystectomyBiliary Tract Surgical Procedures

Study Officials

  • Dmitriy А Pyhteev, PhD

    Head of the Department of Pediatric Surgery

    STUDY DIRECTOR
  • Leonid M Elin

    Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2024

First Posted

November 6, 2024

Study Start

November 13, 2024

Primary Completion

February 20, 2025

Study Completion

March 5, 2025

Last Updated

March 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

A complete dataset can be provided upon reasoned request

Locations